News

The company received FDA approval for Natazia in May 2010 for the prevention of pregnancy. The contraceptive efficacy of Natazia has not been evaluated in women with a

The company said the formulation will be platformed at in-cosmetics event, to be held in Barcelona, Spain next month, according to cosmeticsdesign-europe.com. AAK’s new ingredient is used in

Escitalopram Oxalate Tablet is the generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment tablets. Teva has received a 180-day period of marketing exclusivity as it

Omnaris nasal spray is indicated for the treatment of seasonal allergic rhinitis (SAR) nasal symptoms and for perennial allergic rhinitis (PAR) nasal symptoms. The corticosteroid is composed of

The drug discovery collaboration will utilize Numerate’s in silico drug design technology to generate drug leads for an undisclosed cardiovascular disease target. The platform will feature a set

The liposomal delivery technology is used in the development and commercialization of DNAi-based therapeutics. As per the agreement, Marina could receive up to $14m for each gene target

The company expects to launch the product in the US in the third quarter of 2012. BINOSTO is a treatment option for those patients who have difficulty with

Mobile Intelligence solution allows Gedeon Richter Spain to exercise superior control over spending and commercial operations. The solution also provides advanced profiling, planning and targeting tools which empower

MedPodium Nutra-Apps capsules are small, sealed and come in one-and-done dosing to promote personal health and well being. Under the partnership, NPI distributes Nutra-Apps products to retail and